Skip to main content

Table 2 A comparison of crude prevalence rates (%) for the markers HBsAg and anti-HCV in Rethymnon and Hania over the 1992–6 period.

From: Prevalence of hepatitis B and C markers in high-risk hospitalised patients in Crete: a five-year observational study

 

Rethymnon %

 

Hania %

Difference in prevalence

95%CI

Males

HBsAg

2.03

2.80

-0.008

(-0.013, -0.003)*

 

anti-HCV

4.70

2.73

0.020

(0.011, 0.028)**

Females

HBsAg

0.94

1.73

-0.008

(-0.012, 0.004)**

 

Anti-HCV

5.64

1.97

0.037

(0.027, 0.046)**

  1. *p < 0.001, **p < 0.0001, CI : Confidence Interval